Related Experiment Video

Updated: Nov 26, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.9K

Pharmacological Inhibition of CDK8 in Triple-Negative Breast Cancer Cell Line MDA-MB-468 Increases E2F1 Protein,

Jensen M Spear1, Zhixin Lu1, Wade A Russu1

  • 1Department of Pharmaceutics and Medicinal Chemistry, Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95211, USA.

Molecules (Basel, Switzerland)
|December 9, 2020
PubMed

Insights

Cyclin-dependent kinase 8 (CDK8) inhibition decreases cancer cell viability and increases apoptosis. However, triple-negative breast cancer cells show unique STAT3 and E2F1 pathway responses not seen in colon cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cyclin-dependent kinase 8 (CDK8) is recognized as a colon cancer oncogene.
  • CDK8 is also implicated in acute myelogenous leukemia (AML) and certain breast cancers.
  • Understanding differential responses to CDK8 inhibition is crucial for targeted cancer therapies.

Purpose of the Study:

  • To investigate the distinct biological effects of CDK8 inhibition in colon cancer cell lines versus triple-negative breast cancer (TNBC) cells.
  • To elucidate the specific molecular mechanisms driving differential responses to CDK8 inhibition.

Main Methods:

  • Utilized CDK8 inhibitor 4 to treat various colon cancer cell lines and the MDA-MB-468 TNBC cell line.
  • Assessed cell viability and apoptosis rates post-treatment.
  • Analyzed signal transducer and activator of transcription 3 (STAT3) phosphorylation.
  • Investigated the role of transcription factor E2F1 in mediating cellular responses.

Main Results:

  • CDK8 inhibition led to reduced cell viability and increased apoptosis across all tested cell lines.
  • MDA-MB-468 cells exhibited increased STAT3 phosphorylation, a response not observed in colon cancer cells.
  • STAT3 phosphorylation in MDA-MB-468 cells was dependent on elevated E2F1 protein levels.
  • These findings align with prior research on E2F1-induced apoptosis in MDA-MB-468 cells.

Conclusions:

  • CDK8 inhibition affects cancer cells differently, with TNBC cells showing unique STAT3 and E2F1 pathway activation.
  • E2F1-STAT3 signaling axis plays a critical role in mediating apoptosis in response to CDK8 inhibition in TNBC.
  • Further research into these differential mechanisms could lead to more effective, personalized cancer treatments.
Keywords:
CDK8E2F1MDA-MB-468 cellsSTAT3breast cancerpiperazinylpyrimidinequinazoline

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.6K
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.5K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K